25 LLC’s Pulse Biosciences PLSE Stock Holding History

25 LLC’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-101	Closed	-$727	–	410
2023 Q2	$727	Hold	101	–	–	﹤0.01%	323
2023 Q1	$811	Buy	+101	New	+$305	﹤0.01%	245

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM

Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

25 LLC's PLSE Position: Q3 2023 in Review

25 LLC sold out of Pulse Biosciences (PLSE) in Q3 2023, closing a stake of 101 shares — an estimated $727 sold.

25 LLC first reported a position in PLSE in Q1 2023 and held it in 2 quarters. The position peaked at $811 in Q1 2023. 43 funds tracked by Wall St. Rank hold PLSE as of Q3 2023.

25 LLC reported no remaining Pulse Biosciences position as of Q3 2023 after selling out during the quarter.
25 LLC sold 101 Pulse Biosciences shares in Q3 2023, an estimated $727.
25 LLC first reported a position in Pulse Biosciences in Q1 2023 and held it in 2 quarters.
25 LLC's Pulse Biosciences position peaked at $811 in Q1 2023.
43 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.